Patrick Thiebaud

Summary

Publications

  1. pmc Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy
    Bimal V Patel
    MedImpact Healthcare Systems, Inc, 10680 Treena Street, San Diego, CA 92131, USA
    BMC Fam Pract 9:61. 2008
  2. pmc Impact of disease management on utilization and adherence with drugs and tests: the case of diabetes treatment in the Florida: a Healthy State (FAHS) program
    Patrick Thiebaud
    Pfizer Health Solutions, New York, New York, USA
    Diabetes Care 31:1717-22. 2008
  3. ncbi request reprint Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States
    Bimal V Patel
    MedImpact Healthcare Systems, Inc, San Diego, CA 92131, USA
    J Clin Hypertens (Greenwich) 9:692-700. 2007
  4. ncbi request reprint Compliance with drug therapies for the treatment and prevention of osteoporosis
    Jeffrey S McCombs
    Department of Pharmaceutical Economics and Policy, School of Pharmacy, University of Southern California, Los Angeles, CA, USA
    Maturitas 48:271-87. 2004
  5. ncbi request reprint The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program
    Lizheng Shi
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA
    J Affect Disord 82:373-83. 2004
  6. ncbi request reprint The effect of switching on compliance and persistence: the case of statin treatment
    Patrick Thiebaud
    Department of Pharmaceutical Economics and Policy, School of Pharmacy University of Southern California, 1540 East Alcazar Street, CHP 140, Los Angeles, CA 90033, USA
    Am J Manag Care 11:670-4. 2005
  7. ncbi request reprint Impact of rofecoxib withdrawal on cyclooxygenase-2 utilization among patients with and without cardiovascular risk
    Patrick Thiebaud
    University of Southern California, Los Angeles, CA, USA
    Value Health 9:361-8. 2006
  8. ncbi request reprint The demand for statin: the effect of copay on utilization and compliance
    Patrick Thiebaud
    Department of Pharmaceutical Economics and Policy, University of Southern California, School of Pharmacy, Los Angeles, CA 90033, USA
    Health Econ 17:83-97. 2008
  9. pmc Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen
    Bimal V Patel
    MedImpact Healthcare Systems, Inc San Diego, CA, USA
    Vasc Health Risk Manag 4:673-81. 2008

Detail Information

Publications9

  1. pmc Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy
    Bimal V Patel
    MedImpact Healthcare Systems, Inc, 10680 Treena Street, San Diego, CA 92131, USA
    BMC Fam Pract 9:61. 2008
    ....
  2. pmc Impact of disease management on utilization and adherence with drugs and tests: the case of diabetes treatment in the Florida: a Healthy State (FAHS) program
    Patrick Thiebaud
    Pfizer Health Solutions, New York, New York, USA
    Diabetes Care 31:1717-22. 2008
    ....
  3. ncbi request reprint Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States
    Bimal V Patel
    MedImpact Healthcare Systems, Inc, San Diego, CA 92131, USA
    J Clin Hypertens (Greenwich) 9:692-700. 2007
    ..The lesser degree of compliance and persistence observed in patients receiving diuretics compared with other antihypertensive medications may have public health as well as cost implications...
  4. ncbi request reprint Compliance with drug therapies for the treatment and prevention of osteoporosis
    Jeffrey S McCombs
    Department of Pharmaceutical Economics and Policy, School of Pharmacy, University of Southern California, Los Angeles, CA, USA
    Maturitas 48:271-87. 2004
    ..This study used paid claims data from real-world treatment settings to investigate the impact of hormone replacement therapy (HRT), bisphosphonate and raloxifene on patients with a recorded diagnosis of osteoporosis...
  5. ncbi request reprint The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program
    Lizheng Shi
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA
    J Affect Disord 82:373-83. 2004
    ..This study compares hospital use, suicide risk and health care costs of antidepressant patients with recognized bipolar disorders (recognized-BP) and unrecognized bipolar disorders (unrecognized-BP) with non-bipolar (non-BP) patients...
  6. ncbi request reprint The effect of switching on compliance and persistence: the case of statin treatment
    Patrick Thiebaud
    Department of Pharmaceutical Economics and Policy, School of Pharmacy University of Southern California, 1540 East Alcazar Street, CHP 140, Los Angeles, CA 90033, USA
    Am J Manag Care 11:670-4. 2005
    ..To determine the effect of switching drugs on the compliance and persistence of new statin users...
  7. ncbi request reprint Impact of rofecoxib withdrawal on cyclooxygenase-2 utilization among patients with and without cardiovascular risk
    Patrick Thiebaud
    University of Southern California, Los Angeles, CA, USA
    Value Health 9:361-8. 2006
    ..To compare how cyclooxygenase-2 (COX-2) users with and without cardiovascular (CV) risks responded to the withdrawal of rofecoxib on September 30, 2004...
  8. ncbi request reprint The demand for statin: the effect of copay on utilization and compliance
    Patrick Thiebaud
    Department of Pharmaceutical Economics and Policy, University of Southern California, School of Pharmacy, Los Angeles, CA 90033, USA
    Health Econ 17:83-97. 2008
    ..These results suggest that specific financial incentives given to less compliant patients could improve compliance with statin treatment at a relatively low cost...
  9. pmc Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen
    Bimal V Patel
    MedImpact Healthcare Systems, Inc San Diego, CA, USA
    Vasc Health Risk Manag 4:673-81. 2008
    ..61-3.10) vs other CCB + other statin (all p<0.0001). Single-pill amlodipine/atorvastatin may provide clinical benefits through improving adherence, offering clinicians a practical solution for cardiovascular risk management...